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Abstract
Over the past few decades, magnetic resonance imaging has been utilized as a powerful imaging modality to
evaluate the structure and function of various organs in the human body, such as the brain. Additionally, diffusion
and perfusion MR imaging have been increasingly used in neurovascular clinical applications. In diffusion
weighted magnetic resonance imaging, the mobility of water molecules is explored in order to obtain information
about the microscopic behaviour of the tissues. In contrast, perfusion weighted imaging uses tracers to exploit
hemodynamic status, which enables researchers and clinicians to consider this imaging modality as an early
biomarker of certain brain diseases. In this review, the fundamentals of physics for diffusion and perfusion MR
imaging – both of which are highly sensitive to microenvironmental alterations at the cellular level – as well as
their application in the treatment of aging, Alzheimer's disease, brain tumors and cerebral ischemic injury were
discussed.
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Introduction
Various MR techniques have been developed to identify the
brain mechanisms underlying complex cognitive, motor, and
other behavioral functioning [11]. While diffusion weighted
magnetic resonance imaging (DWI) makes use of the transla-
tional mobility of water molecules and provides information
regarding the microscopic behaviour of the tissues in the pres-
ence of macromolecules, the presence and permeability of
membranes, and the equilibrium of intracellular-extracellular
water, perfusion weighted imaging uses the endogenous and
exogenous tracers and obtains hemodynamic status. Research
has shown that the use of both modalities is extremely bene-
ficial in the early detection and assessment of various brain
issues, such as stroke, tumor characterisation, and the evalua-
tion of neurodegenerative diseases (aging and Alzheimer's dis-
ease) [18]. MR diffusion weighted imaging (DWI) measures
the signal loss associated with the random thermal motion of
water molecules in the magnetic field to estimate a parameter
which is referred to as the apparent diffusion coefficient. This
parameter directly defines the translational mobility of the wa-
ter molecules in the tissues. As mentioned previously, these
techniques are used in the early detection and assessment of
stroke, tumor characterisation, and the evaluation of multiple
sclerosis as well as age-related disease. Perfusion weighted
imaging (PWI) allows for the inference of how blood traverses
the brain's vasculature. PWI measures the effects of endoge-
nous or exogenous tracers on MR images in order to derive
various hemodynamic quantities, such as cerebral blood vol-
ume, cerebral blood flow and mean transit time. Although
DWI and PWI can separately provide information, in practice,
a combination of both modalities can prove much more useful
than a single modality [18].
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1. Diffusion and Perfusion MRI: Basic
Physics
1.1 Diffusion weighted imaging
In MR spectroscopy, signal attenuation is caused by molecular
diffusion in the presence of a magnetic field gradient. In 1965,
Stejskal and Tanner developed the pulsed gradient, forming
the basis of modern diffusion weighted imaging techniques
[18]. Brownian motion results in molecular diffusion that rep-
resents a constant random flow of individual molecules in a
fluid state due to thermal agitation. The average displacement
of the molecules remains zero, but over time, the probability
of finding an individual molecule at a distance from its point
of origin is not zero. In reality, the root-mean-square dis-
placement increases in proportion to the square root of time,
the constant of proportionality being a diffusion constant D,
characterising the fluid studied. The diffusion coefficient of
pure water is about 2.2×103 mm2s Soft tissues tend to behave
much like aqueous protein solutions. Additionally, due to the
reduced mobility of the water molecules, the corresponding
diffusion coefficient is generally smaller than that of pure
water. In many tissues, boundaries with various degrees of
permeability hinder the free diffusion of water, further de-
creasing the diffusion coefficient. Applying the Brownian
motion model in these circumstances leads to an ‘apparent
diffusion coefficient,'or ADC, which must be distinguished
from the diffusion coefficient of free water molecules. In
tissues such as white brain matter, an additional complication
arises from the fact that molecular mobility is not the same
in all directions, i.e., the diffusion process is anisotropic, and
the scalar diffusion coefficient must be replaced by a tensor
quantity. Scalar diffusion model In an isotropic environment,
molecular mobility is described by a scalar diffusion coeffi-
cient in which the Brownian motion is similar in all spatial
directions. In the absence of magnetic field gradients, the
signal is unaffected by the presence of incoherent motion. As
soon as field gradients are switched on during any stage of
the signal preparation, the motion leads to spin dephasing
that, due to the random nature of the successive trajectories
of each individual molecule, cannot be undone. The result is
an exponential attenuation of the original signal, as shown in
Equation 1.
S = S0(N(H),T1,T2)x−bD (1)
Where D is the (apparent) diffusion coefficient of the medium
and b is a scalar reflecting the properties of the gradient G (t).
1.2 Tensor diffusion model
Based on the morphology, many tissues demonstrate anisotropic
diffusion behavior in which the ADC values that are measured
using the Stejskal–Tanner sequences are determined by the
direction of the sensitizing gradient. For an anisotropic diffu-
sion process, Equation 1 is updated as the following (Equation
2):
S = S0(N(H),T1,T2)x−∑bi jDi j (2)
Where i and j can be any of the three spatial directions: x,y,z
in an orthogonal frame of reference. The bi j factors charac-
terize the sensitizing gradients along the i and j directions.
This tensor is symmetrical and contains only six independent
elements, the determination of which requires the acquisition
of images with at least two different diffusion weightings for
each of at least six independent directions of the sensitizing
gradient. The information in the diffusion tensor may be con-
ceptualized using a “diffusion ellipsoid” picture: the portion
of space within which we can expect a molecule to end up
due to its aleatory motion, which expands around the point
of origin as time goes by and, in general, has the shape of a
flattened cigar, reflecting anisotropic mobility.
1.3 Perfusion weighted imaging
One of the early approaches to perfusion weighted MRI was
to compare the aleatory nature of the motion of blood through
the randomly oriented capillaries to that of Brownian mo-
tion. In this method, there was success in using the principles
of diffusion weighted MR for estimating blood flow. This
method, which is also called the “intra-voxel incoherent mo-
tion” (IVIM) technique, has recently been replaced by meth-
ods that rely on magnetic susceptibility and inflow effects.
Susceptibility PWI is based on the passage of intravascular
tracers like Gd-DTPA through the capillaries, producing a
transient signal loss due to susceptibility effects and allowing
first-pass kinetics of the agent to be applied. PWI with arterial
spin tagging utilizes the blood itself, with suitably prepared
magnetization, as an endogenous tracer. Based on certain
assumptions, perfusion imaging allows for the estimation of
several important hemodynamic parameters such as cerebral
blood volume (CBV), defined as the fraction of the total tissue
volume within a voxel occupied by blood; and cerebral blood
flow (CBF) or perfusion, defined as the volume of arterial
blood delivered to the tissue per minute per tissue volume and
the mean transit time (MTT), which corresponds to the aver-
age time it takes a tracer molecule to pass through the tissue
[18]. Figure 1 shows a schematic of a diffusion weighted MRI
technique (Figure 1).
2. Diffusion and Perfusion MRI of the
Brain
2.1 Aging
For several years, research has demonstrated that brain struc-
ture and functional change by aging and older adults causes
particular difficulties with episodic memory, which is defined
as the conscious recollection of events. Older adults are also
more susceptible to the effects of distracting interference dur-
ing cognitive tasks and have a generally slower processing
speed. Nevertheless, some aspects of cognition are main-
tained with age, such as semantic memory (the accumulation
of knowledge about the world) and emotional regulation. In
addition, age differences in cognition are not immutable: for
example, the experimental conditions under which memory
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Figure 1. Schematic overview of diffusion weighted MRI
methodology (Image courtesy: Luypaert et al.)
is studied in older adults can be modified so that age differ-
ences are reduced or eliminated. Decreased brain activity has
typically been interpreted as a reflection of cognitive deficits
in older adults, and increased activity has often been inter-
preted as compensatory. Another issue is how brain activity
is related to other aspects of brain aging, such as changes in
structure (volumes or white matter myelination, for example)
or changes in neurotransmitters. There is also the question
of how findings regarding age differences in brain function
might be affected by undetected neuropathological changes
due to dementing illnesses. That is, some otherwise healthy
older adults might eventually be diagnosed with Alzheimer's
disease, and the ‘silent'pathological processes in their brains
might account for some of the findings tied to age differences
reported in the literature [5]. Normal aging and senescence are
defined by various well-established structural magnetic reso-
nance imaging correlates. Enlargement of perivascular spaces
and generalized atrophy with enlargement of the ventriculi
and the sulci are commonly observed. Deep and subcortical
white matter hyperintensities and periventricular hyperinten-
sities are assumed to be due to axonal loss, demyelinization,
neuropil atrophy, and vascular damage [12]. Figure 2 sum-
marizes the results of two studies that differ in terms of how
increased brain activity in older adults is associated with task
performance. In one of these studies (study 1), the regions
shown in green demonstrate a correlation between more ac-
tivity and slower reaction times on perceptual and working
memory tasks in older adults. In another experiment (study
2), several brain regions (indicated in purple) demonstrate a
correlation between more activity and more accurate perfor-
mance in a go/no-go task requiring inhibition of responses.
Note that some regions (shown in purple and green) demon-
strate an association with better performance in study 2 and
the opposite effect in study 1. This discrepancy highlights
the complexity of attempts to relate brain activity in older
adults to their behaviour, and it indicates that specific relation-
ships between regional brain activity and task performance in
older adults are dependent upon the task demands or on the
behavioural measure that is assessed (or both). IFG stands for
inferior frontal gyrus; IPL, inferior parietal lobe; ITC, inferior
temporal cortex; MFG, middle frontal gyrus; and VC, visual
cortex.
Figure 2. Increased brain activity in older adults may be
associated with better or worse task performance (Image
Courtesy: Cheryl Grady - Nature)
2.2 White matter systems and age-related decline
in frontally based functions
The constellation of frontally based functions, including work-
ing memory, set shifting, problem solving, attention, and other
executive functions is especially vulnerable to the undesirable
effects of advancing age. Although controversy exists re-
garding the primacy of the frontal lobe hypothesis to explain
age-related functional declines, substantial evidence supports
the position that aging disproportionately affects the frontal
lobe structure. Identification of brain mechanisms responsible
for this time-linked functional demise currently focuses on
the health of white matter systems necessary to form neural
circuits of frontal processing sites. Although performance
of executive functions becomes inefficient with age, execu-
tive functioning is still possible and in fact may be enhanced
when older individuals recruit wider-spread brain systems
than those invoked by younger adults. In addition to provid-
ing interhemispheric communication for sensory and motor
integration, corpus callosum integrity may influence the al-
location of resources when attentional or memory capacity
is limited. Some have interpreted the bilateral pattern as evi-
dence of decline in functional hemispheric laterality, arising
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Figure 3. The graphs (A) and within- and between-network
connections (B) for young and older adults are shown for the
resting state fMRI data. The DAN is represented in red, FPC
in green, and DMN in blue. The FPC lies between the other 2
networks in both groups, although some nodes have been
assigned to non-canonical networks in the older group. Each
metric (in B) was calculated as the proportion of connections
within or between networks (out of the total possible) for
each node and then averaged across nodes for each network.
Reassigned nodes in older adults were considered to be part
of the network as they appear in (A) (e.g., nodes C02, C08,
C09, C12 and C15 were included in the DAN for the
calculations seen in [B]). Abbreviations: DAN, dorsal
attention network; DMN, default mode network [6] [16] [1].
from compromise of the callosum's capacity to inhibit par-
ticipation of the hemisphere less suited to accomplish a task.
The outcome can appear as “dedifferentiation”of hemispheric
function [11]. Cross-sectional and longitudinal structural MRI
studies consistently show that age-related volume increases
in CSF-filled spaces which occur primarily at the expense of
cortical gray matter, with most showing little volume change
in white matter, as shown in Figure 3.
Figure 4. A cross-sectional study revealed age-related
decline in cortical gray but not white matter volumes in
healthy adults (95 men and 48 women) [11].
2.3 Imaging Correlates of Aging and Alzheimer's dis-
ease
Alzheimer's disease and neurodegenerative dementias are
growing health problems, since populations are constantly
aging. The diagnosis of neurodegenerative diseases is there-
fore a challenge for modern neuroimaging techniques that
extends well beyond their traditional role of excluding other
conditions such as neurosurgical lesions [9] [23] [24]. A ro-
bust imaging-based algorithm such as Deep Learning, which
is able to classify Alzheimer's disease, will assist scientists and
clinicians in diagnosing this brain disorder and will also aid in
the accurate and timely diagnosis of Alzheimer's patients [14]
[15]. Additionally, through the assessment of cerebral blood
flow in AD with spin labeling techniques, MRI has the poten-
tial to assist in the diagnosis of neurodegenerative dementias.
In general, structural MRI is used to recognize Alzheimer's
disease, and functional MRI (fMRI) is also used for research
purposes. Because this form of brain degeneration affects the
brain structure, structurally based MRI techniques are utilized
for early detection of Alzheimer's disease. In addition to MR
morphometry, several recent imaging techniques have demon-
strated the potential to detect early abnormalities in AD pa-
tients that may be useful in the clinical diagnosis of dementias.
These techniques include perfusion, diffusion, spectroscopy
and microscopy. Perfusion MRI techniques can assess cere-
bral perfusion (cerebral blood volume and cerebral blood
flow). They therefore have the potential to depict functional
deficiencies in a manner that is similar to HMPAO SPECT.
Techniques using radiotracers have consistently shown a re-
duction in cerebral blood flow in patients with AD in the
temporo-parietal association areas, the posterior cingulate cor-
tex, and, to a lesser extent, in frontal association areas, while
the primary motor and sensory areas are generally spared.
Cerebral perfusion can be assessed using contrast-enhanced
techniques that require the injection of a paramagnetic contrast
agent. In Alzheimer's disease patients, reduced perfusion was
reported in parietal areas using contrast-enhanced perfusion
imaging [9]. As mentioned previously, diffusion weighted
imaging (DWI) is sensitive to the random motion of water
molecules in the brain. Measures of water diffusivity from
DWI provide an estimate of the microstructural integrity of
the brain parenchyma Increased diffusivity has been reported
in the temporal lobe and the posterior white matter of patients
with Alzheimer's disease, as well as MCI subjects. Increased
diffusivity may reflect a change in the ultrastructural organi-
zation of brain tissue or may represent an index of neuronal
atrophy. In contrast, brain anisotropy was decreased in sev-
eral white matter regions, including the corpus callosum, the
cingulum, the superior longitudinal fasciculus or the area of
the perforant pathway, reflecting a change in the white matter
bundles connecting the affected brain areas in AD patients. In
MCI subjects, higher baseline hippocampal diffusivity was
associated with a greater risk of progression to AD. Much
like voxel-based morphometry, voxel-based comparison of
anisotropy maps showed reduced FA in posterior brain regions.
DTI abnormalities revealed some correlation with measures
of cognitive performance. Left hippocampal volumes were
associated with poor verbal memory performance, particularly
when associated with high diffusivity values. In Figure 5, the
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anisotropic nature of diffusion in the brain by transverse DW
MR images is demonstrated [17].
Figure 5. Anisotropic nature of diffusion in the brain.
Transverse DW MR images (b = 1,000 sec/mm2); effective
gradient, 14 mT/m; repetition time, 7,500 msec; minimum
echo time; matrix, 128 3 128; field of view, 200 3 200 mm;
section thickness, 6 mm with 1-mm gap) with the diffusion
gradients applied along the x (Gx, left), y (Gy, middle), and z
(Gz, right) axes demonstrate anisotropy. The signal intensity
decreases when the white matter tracts run in the same
direction as the DW gradient because water protons move
preferentially in this direction. Note that the corpus callosum
(arrow on left image) is hypo-intense when the gradient is
applied in the x (right-to-left) direction, the frontal and
posterior white matter (arrowheads) are hypo-intense when
the gradient is applied in the y (anterior-to-posterior)
direction, and the corticospinal tracts (arrow on right image)
are hypo-intense when the gradient is applied in the z
(superior-to-inferior) direction.
2.4 Brain Tumors
Imaging of the response to oncology treatments, in both clini-
cal protocol and standard practice, is a complicated process
that has progressed during the last 20 years as modern imaging
technologies and newer modalities have been developed. One
of the most important questions in the field of oncology is how
any tumor response or progression is determined. A unique
method to define tumor response is not completely acceptable.
As a result, a new definition for solid tumor responses based
on a single linear summation of a small number of target le-
sions, termed Response Evaluation Criteria in Solid Tumors
(RECIST), has been adopted for clinical protocols. This linear
summation is both rapid and reproducible, which facilitates its
use in clinical trials. RECIST also represents a step forward
from previous response criteria, since it takes into account
differences in scan thickness, minimum tumor size, and fre-
quency of evaluation. Novel functional imaging modalities
such as perfusion MRI, diffusion MRI, [18F] fluorodeoxyglu-
cose positron emission tomography (PET), or PET with newer
tracers provide higher resolution and reproducibility of tradi-
tional volumetric data. Those imaging modalities now have
the need to evaluate potential new biomarkers for tumor re-
sponse. The main reason for using the imaging modalities
mentioned above is to measure the characteristics of the tumor
before therapy to determine prognostic value. They also allow
for the evaluation of changes in tumors in response to treat-
ment that could function as a surrogate for clinical purposes.
Dynamic contrast enhanced MRI, such as diffusion MRI, pro-
vides images with high spatial resolution and facilitates the
evaluation of tumor vasculature or response to antiangiogenic
therapies. Nevertheless, it requires the use of intravenous con-
trast and relatively complicated post-processing of acquired
images [7] [19] [20]. The helpfulness of diffusion MRI in the
evaluation of stroke led to its exploration as an early marker
of tumor response to therapy, and over the last 22 years, simi-
lar early diffusion changes have been demonstrated to occur
in both preclinical and clinical settings. Given the high con-
centration of water within biologic tissues, diffusion MRI
has focused primarily on measuring the diffusion of protons
present within water molecules. Using this method, the move-
ment of water molecules within a cell can be differentiated
from that in the extracellular space; however, because extracel-
lular water is better able to diffuse than intracellular water, it is
usually the predominant signal in most biologic systems. For
instance, diffusion MRI can accurately discriminate between
a fluid-filled cyst and a cellular mass that would have more
restricted movement of water molecules. Due to a complex
interplay of factors in vivo, the actual diffusion coefficient of
water cannot be measured directly by MRI; instead, the diffu-
sion coefficient obtained from orthogonal diffusion weighted
MRI in all three planes is obtained and is termed the appar-
ent diffusion coefficient (ADC). Diffusion MR measurements
are sensitive and can be used to detect and quantify water
diffusion values in tissues, which have been proposed to be
related to the ratio of intracellular water to extracellular water.
Thus, changes in ADC are inversely correlated with changes
in cellularity, as shown in Figure 6. In this scenario, increases
in ADC will reflect an increase in the mobility of water, ei-
ther through the loss of membrane integrity or through an
increase in the proportion of total extracellular fluid, with a
corresponding decrease in cellular size or number, as seen in
necrosis or apoptosis. In contrast, decreases in ADC reflect a
decrease in free extracellular water, either through an increase
in total cellular size or number, as can be seen with tumor
progression, fibrosis, or edema. Given that molecular and
cellular changes in response to stress, cytotoxicity, or oxida-
tive injury precede volumetric changes, changes in diffusion
MRI have been hypothesized to serve as an early surrogate
for later pathologic or radiologic end points. Early preclinical
evaluations and studies with rodent brain and breast tumor
models revealed that a change in ADC accurately reflected
a change in cellularity and could be measured earlier than
changes in tumor volume. In animal models, treatment of
breast cancer xenografts with cyclophosphamide (150 or 300
mg/kg) produced a significant 30% to 40% increase in ADC
two days after treatment, which preceded volumetric response
as measured using a non-image-based spectroscopic method.
A prospective trial of diffusion MRI in patients with primary
brain tumors was initiated at the University of Michigan (Ann
Arbor, MI). All patients underwent a baseline scan within
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Figure 6. A schematic of the change in cellularity (left) and
increased molecular water mobility measured as an apparent
diffusion coefficient (ADC; right) as a tumor responds to
treatment (top to bottom). For a tumor responding to therapy,
an increase in extracellular space/membrane permeability
allows for greater water mobility and an increase in the ADC.
(Image courtesy: Hamstra et al. 2007)
one week before the start of treatment, followed by the first
intra-treatment scan at three weeks. The majority of patients
were treated with a six-week course of fractionated radiation.
Therefore, when these patients were assessed for response,
less than half of the total course of radiation had been deliv-
ered. In an initial report, mean ADC was weakly correlated
with subsequent radiographic response. However, fDMs were
able to quantify a relatively small responsive mean SEM vol-
ume within the tumors of only 8.1%±3.1% (range, 0% to
25%), and the fDM was able to accurately discriminate be-
tween patients who had a progressive disease, a stable disease,
or a partial response [13] [7] [21] [22]. Figure 7 shows fDMs
[also referred to as parametric response mapping (PRMADC)]
with corresponding scatter plots from patients with head and
neck squamous cell carcinoma (HNSCC) diagnosed as a com-
plete response (CR) (Fig. 7A) and a partial response (PR) (Fig.
7B) following therapy. Through analysis of the diffusion maps
using fDM, heterogeneity in tumor response can be visual-
ized, with red regions denoting a response (i.e., an increase in
ADC from baseline) versus stable and decreased ADC regions
depicted as green and blue, respectively. As demonstrated
in a variety of tumor types, large regions of increased ADC
from the baseline (i.e., red voxels) were strongly correlated
with treatment response, irrespective of the presence of tumor
regions with stable or decreasing ADC values [4] [3].
Figure 7. Functional diffusion mapping (fDM) applied to
clinical data acquired from patients with head and neck
squamous cell carcinoma (HNSCC) diagnosed as pCR
(pathological complete response) (A) and PR (partial
response) (B). Results from the fDM analysis are presented
as color-coded maps superimposed on contrast-enhanced
T1-weighted images and scatter plots with axes pre-treatment
ADC (x-axis) and post-treatment ADC (y-axis). Color coding
is as follows: red, increased ADC values; blue, decreased
ADC values; green, unchanged ADC values. (Image courtesy:
Galban et al. [3])
2.5 Cerebral Ischemic Injury
Diffusion magnetic resonance imaging provides an early marker
of acute cerebral ischemic injury. Thrombolytic reversal of
diffusion abnormalities has not previously been demonstrated
in humans. Serial diffusion and perfusion imaging studies
were acquired in patients experiencing acute hemispheric cere-
bral ischemia treated with intra-arterial thrombolytic therapy
within six hours of symptom onset. Diffusion weighted imag-
ing (DWI) detects decreases in the self-diffusion of water
molecules, appearing as hyper-intensity on DWI sequences as-
sociated with a reduced apparent diffusion coefficient (ADC)
value. These changes, seen within minutes of ischemia, are
related, at least in part, to cellular energy failure and early
cytotoxic edema. Perfusion weighted imaging (PWI) provides
a qualitative map of relative cerebral blood flow to identify
regions of hypo-perfusion. ADC values typically decrease
sharply immediately after stroke onset, remain low for at least
72 to 96 hours, then gradually increase, reaching or surpass-
ing normal levels. Serial studies have shown that the typical
natural history of early acute ischemic diffusion lesion vol-
umes is to grow over time. In various series, between 62%
and 88% of patients imaged initially under six hours exhib-
ited lesion growth on follow-up imaging, with the percent
change in lesion volume ranging from 32% to 107%. It is
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speculated that this lesion growth may be the result of the
gradual failure of energy metabolism in the ischemic penum-
bra as it is recruited into the infarct core if early reperfusion
does not occur. Diffusion/perfusion MRI has been suggested
as a means to identify the ischemic penumbra. A prevalent
view posits that in humans, the area of diffusion abnormality
constitutes an already irreversible core infarction field, and
that the penumbra is the region that will show perfusion but
not yet diffusion abnormality (diffusion/perfusion mismatch).
However, animal studies suggest that this model of the is-
chemic penumbra may underestimate the volume of tissue
that is salvageable early after ischemic onset. When reperfu-
sion occurs within two to three hours in these animal models,
the perfusion deficit resolves and is accompanied by partial
reversal of DWI and ADC abnormalities. We hypothesize
that in humans, as in animals, portions of the DWI and ADC
lesions may be salvaged with early reperfusion [8]. However,
one limitation to the widespread use of physiological MRI
scanning in guiding early decision making in acute stroke
is that diffusion/perfusion MRI is not currently available in
many small, community hospitals. Conversely, MRI with
echo-planar imaging capability is already widely used in large
hospitals and academic stroke centers, where intra-arterial
thrombolysis is likely to be most extensively offered, and is
rapidly disseminating into the community. Although our se-
ries suggests that it is feasible to obtain pre-treatment MRI
scans in acute stroke patients, it is important to emphasize that
this is a labor-intensive task that requires a well-coordinated
stroke team and rapid MRI scanning availability.
3. Conclusion
In this study, the importance as well as the application of
diffusion and perfusion MRI were reviewed. DWI makes
use of signal attenuation due to the random motion of water
molecules in a strong gradient and allows insight into the
microscopic behaviour of the affected tissues, as reflected
by the mobility of the water molecules. PWI allows for the
assessment of regional cerebral hemodynamics using a variety
of methods, among which the first pass endovascular bolus
studies are presently the most commonly used in the clinic.
These imaging modalities provide crucial information about
the aging brain and are considered early biomarkers in the
diagnosis of certain brain disorders such as Alzheimer's dis-
ease and brain tumors. In aging, as an index of brain tissue
quality, DTI allows for the examination of regional patterns
of neural circuitry degeneration associated with aging that
is not possible with other imaging modalities. Finally, DW
MR imaging will also play a greater role in the management
of stroke. It may also be helpful in the selection of patients
for thrombolysis and in the evaluation of new neuroprotec-
tive agents. Additionally, DW MR imaging may prove to be
valuable in the evaluation of a wide variety of other disease
processes, as described in this review.
Figure 8. Serial imaging from a 70-year-old man who
presented with right hemiparesis and aphasia. The baseline
magnetic resonance imaging was obtained 1 hour 15 minutes
after symptom onset. (A) Summary display of the baseline,
early post-thrombolysis, and day 7 data, including diffusion
weighted imaging (DWI), apparent diffusion coefficient
(ADC), T2-weighted (T2), and perfusion weighted images
(PWI). For the color-coded perfusion weighted images, red
represents a bolus delivery delay of greater than 8 seconds,
yellow 7 to 8 seconds, green 5 to 6 seconds, and blue 3 to 4
seconds. Early after thrombolysis, diffusion abnormality
decreases substantially in size, and the perfusion deficit
resolves. The day 7 study shows reduced DWI and ADC
lesion volumes and a small final T2 infarct volume. (B)
Diffusion weighted images of consecutive axial sections from
the same patient at baseline and early after thrombolysis,
demonstrating marked reductions in lesion volume at multiple
levels. (C) Perfusion weighted images of consecutive axial
sections from the same patient at baseline and early after
thrombolysis, demonstrating marked reductions in lesion
volume at multiple levels. Following thrombolysis, the
patient's aphasia and hemiparesis gradually improved, with
National Institutes of Health Stroke Scale score decreasing
from 24 at baseline to 17 early after thrombolysis to 13 at day
7. (Image courtesy: Kidwell et al. [8])
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